Needle suspension procedures are simpler than abdominal suspension procedures and are less invasive (because they require smaller/fewer incisions and punctures). A surgeon named Pereyra first described transvaginal (through the vagina) needle suspension in 1959. Since that time, numerous surgical adaptations have been developed, each named after its creator (Stamey, Raz, Gittes, etc.); however, the principles of needle suspension remain the same. In essence, sutures are placed blindly through the pubic skin or via vaginal incision into the anchoring tissues on each side of the bladder neck. The bladder neck then is supported by the sutures, which are threaded on a needle and tied to the fascia (fibrous tissue) or the pubic bone. Operative times and recovery periods are shorter for needle suspension versus other suspension techniques. Some healthcare facilities even conduct needle suspensions as outpatient procedures. The Stamey technique can be performed both vaginally and through a small incision above the pubic bone. A nylon suture is used to suspend the urethra on each side. Cystoscopy is employed to ensure that the urethra and bladder are not injured during the procedure. (Note: When endoscopy -- visual examination of the bladder by means of a tiny, telescope-like device connected to a video camera -- is used to examine the organs of the abdominal cavity, the procedure is called laparoscopy.) The Raz procedure often is chosen for patients who are incontinent due to urethral and bladder neck hypermobility (dropping down) and who have minimal or no cystocele (herniation of the bladder into the vagina). An inverted U-shaped incision is made at the base of the anterior (front) vaginal wall, and adhesions (fibrous tissue bands) around the bladder neck and urethra are released. A needle is passed through the surgical incision, and the suspending sutures are pulled up, lifting the front of the vagina and urethra. The Raz procedure is very similar to the Stamey procedure, but the sutures are not placed near the urethra; instead, they are placed in the front of the vaginal wall. The Gittes procedure is a transvaginal technique that does not require an incision. Instead, a small puncture is made above the pubic fat pad. A suture is then transferred by a needle through the rectus (muscle of the pubic crest) and down toward the vaginal wall, where it is looped and drawn back and out through the puncture. A second pass is made through the same incision (1 or 2 cm beside the first pass) to create a strong support for the suspension. The process is repeated through another puncture hole, which is made 1.5 to 2.0 cm away from the first site. Both suspending sutures are tied down within their respective puncture sites. Bone anchors are new additions to the techniques for needle suspension of the bladder neck. When needle suspension was first developed, surgeons questioned the amount of tension that was suitable for the suspension sutures. They wanted to avoid the complications of bladder outlet obstruction and suture breakdown that could because by too much tension or sutures pulling out of the anchoring tissue. Recent innovations, such as the vesica® bladder suspension kit and Intac/Infast kits, employ bone anchoring devices to improve the needle suspension procedures. With vesica®, a disposable suture carrier creates a large Z-stitch that is used move pubic fascia beside the bladder neck and urethra. Next, the suspension sutures are fixed to an anchor that is inserted into the pubic bone and they are tied without tension by means of a removable spacer. Bone anchoring is not a very painful procedure and can be performed on an outpatient basis. Patients with severe stress incontinence and intrinsic sphincter deficiency (Type III SUI or weakening of the urethra muscle) may not be helped by simple suspension procedures. Yet such individuals are good candidates for the pubovaginal sling procedure, which can create the urethral compression necessary to achieve bladder control. This technique involves the creation of an autologous sling -- that is, a sling made out of a strip of tissue from the patient's own abdominal fascia (fibrous tissue). Occasionally, surgeons use a synthetic (artificial, man-made) sling for this procedure, although urethral erosion (breakdown) appears to be more common when synthetic slings are used.
Removal of an entire kidney. 
Incontinence may be related to defects in the nervous system, which conducts urination signals between the bladder and the brain. Such cases of neurogenic bladder -- for example, in patients with diabetes, Parkinson's disease, or myelomeningocele (bulging out of the spinal cord through a defect in the spine) -- may not be associated with the severe irritative symptoms seen in bladder infections. Instead, patients may have severe, total incontinence, a rigid bladder and a nonfunctional sphincter mechanism.
The NMP22TM assay measures specific proteins from the nuclear matrix (cell center). It can detect transitional cell carcinoma (TCC) with a sensitivity of roughly 67%, meaning that 67% of existing TCCs are detected. But, perhaps more importantly, the NMP22TM assay it is able to predict the recurrence of bladder cancer after transurethral resection (TUR) for invasive cancer with an overall sensitivity of 70% (see also Treatment of Bladder Cancer). The BTA TRAK® test measures the levels of a specific protein (human complement factor H-related protein, or hCFHrp) that is detected by the BTA stat test.
Nonbacterial prostatitis (NBP), also known as chronic pelvic pain syndrome (CPPS), is the most common and least understood form of prostatitis. It is a condition in which the patient exhibits many of the symptoms of prostatitis without any demonstrable infection.
Several noninvasive, or external, devices are among the newer promising treatments for stress incontinence. The Miniguard Patch and Impress (Uromed) are single-use foam pads that are slightly larger than a postage stamp. One surface of the patch is covered with gel-like glue that adheres to the region around the opening of the urethra. The patch fits between the labial folds and provides opposing pressure on the urethra to prevent leakage. When the wearer wants to urinate, she simply removes the patch and applies a new one afterward. The patch is less bulky than cumbersome pads and provides a neater alternative for leakage. FemAssist and Bard Cap Sure Continence Shields are external devices that function like foam pads, but can be reused used for about one week before being replaced. Both are small, circular, silicone rubber devices that are positioned over the flat area surrounding the urethra. Using suction, they support and reinforce the muscle that naturally control urine output and help prevent accidental urine loss in women who suffer from stress incontinence. An ointment is used to create a mild vacuum seal that holds the device in place. When a woman wants to urinate, she removes the device, which can then be cleaned and reapplied. Because they are used externally, FemAssit and CapSure have lower rates of associated infection than internal devices, though some woman report discomfort or mild irritation when using these products.